These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28993326)

  • 41. Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.
    Taft BR; Yokokawa F; Kirrane T; Mata AC; Huang R; Blaquiere N; Waldron G; Zou B; Simon O; Vankadara S; Chan WL; Ding M; Sim S; Straimer J; Guiguemde A; Lakshminarayana SB; Jain JP; Bodenreider C; Thompson C; Lanshoeft C; Shu W; Fang E; Qumber J; Chan K; Pei L; Chen YL; Schulz H; Lim J; Abas SN; Ang X; Liu Y; Angulo-Barturen I; Jiménez-Díaz MB; Gamo FJ; Crespo-Fernandez B; Rosenthal PJ; Cooper RA; Tumwebaze P; Aguiar ACC; Campo B; Campbell S; Wagner J; Diagana TT; Sarko C
    J Med Chem; 2022 Mar; 65(5):3798-3813. PubMed ID: 35229610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hollow-Fiber Methodology for Pharmacokinetic/Pharmacodynamic Studies of Antimalarial Compounds.
    Caton E; Nenortas E; Bakshi RP; Shapiro TA
    Curr Protoc Chem Biol; 2016 Mar; 8(1):29-58. PubMed ID: 26995353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative.
    Tsamesidis I; Mousavizadeh F; Egwu CO; Amanatidou D; Pantaleo A; Benoit-Vical F; Reybier K; Giannis A
    Medicines (Basel); 2022 Jan; 9(2):. PubMed ID: 35200752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens.
    Aljayyoussi G; Kay K; Ward SA; Biagini GA
    Malar J; 2016 Jul; 15(1):344. PubMed ID: 27388207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment.
    Hodel EM; Kay K; Hastings IM
    Antimicrob Agents Chemother; 2016 May; 60(5):2747-56. PubMed ID: 26902760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artemisinin Antimalarials: Preserving the "Magic Bullet".
    Maude RJ; Woodrow CJ; White LJ
    Drug Dev Res; 2010 Feb; 71(1):12-19. PubMed ID: 21399699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of
    Walz A; Duffey M; Aljayyoussi G; Sax S; Leroy D; Besson D; Burrows JN; Cherkaoui-Rbati MH; Gobeau N; Westwood MA; Siethoff C; Gamo FJ; Mäser P; Wittlin S
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37009844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model.
    Demarta-Gatsi C; Andenmatten N; Jiménez-Díaz MB; Gobeau N; Cherkaoui-Rabti MH; Fuchs A; Díaz P; Berja S; Sánchez R; Gómez H; Ruiz E; Sainz P; Salazar E; Gil-Merino R; Mendoza LM; Eguizabal C; Leroy D; Moehrle JJ; Tornesi B; Angulo-Barturen I
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157422. PubMed ID: 37133382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in
    Tsamesidis I; Reybier K; Marchetti G; Pau MC; Virdis P; Fozza C; Nepveu F; Low PS; Turrini FM; Pantaleo A
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome.
    Bridgford JL; Xie SC; Cobbold SA; Pasaje CFA; Herrmann S; Yang T; Gillett DL; Dick LR; Ralph SA; Dogovski C; Spillman NJ; Tilley L
    Nat Commun; 2018 Sep; 9(1):3801. PubMed ID: 30228310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers.
    Okour M; Derimanov G; Barnett R; Fernandez E; Ferrer S; Gresham S; Hossain M; Gamo FJ; Koh G; Pereira A; Rolfe K; Wong D; Young G; Rami H; Haselden J
    Br J Clin Pharmacol; 2018 Mar; 84(3):482-489. PubMed ID: 29168205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Machine learning for artemisinin resistance in malaria treatment across
    Zhang H; Guo J; Li H; Guan Y
    iScience; 2022 Mar; 25(3):103910. PubMed ID: 35243261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nutrient Limitation Mimics Artemisinin Tolerance in Malaria.
    Brown AC; Warthan MD; Aryal A; Liu S; Guler JL
    mBio; 2023 Jun; 14(3):e0070523. PubMed ID: 37097173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Click Chemistry-Based Proteomic Approach Reveals that 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile.
    Ismail HM; Barton VE; Panchana M; Charoensutthivarakul S; Biagini GA; Ward SA; O'Neill PM
    Angew Chem Weinheim Bergstr Ger; 2016 May; 128(22):6511-6515. PubMed ID: 27397940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
    Phompradit P; Chaijaroenkul W; Na-Bangchang K
    Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.
    Apinjoh TO; Mugri RN; Miotto O; Chi HF; Tata RB; Anchang-Kimbi JK; Fon EM; Tangoh DA; Nyingchu RV; Jacob C; Amato R; Djimde A; Kwiatkowski D; Achidi EA; Amambua-Ngwa A
    Infect Dis Poverty; 2017 Nov; 6(1):136. PubMed ID: 29110722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar.
    Landier J; Kajeechiwa L; Thwin MM; Parker DM; Chaumeau V; Wiladphaingern J; Imwong M; Miotto O; Patumrat K; Duanguppama J; Cerqueira D; Malleret B; Rénia L; Nosten S; von Seidlein L; Ling C; Proux S; Corbel V; Simpson JA; Dondorp AM; White NJ; Nosten FH
    Wellcome Open Res; 2017; 2():81. PubMed ID: 29062913
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.
    Sugiarto SR; Davis TME; Salman S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1115-1133. PubMed ID: 29027504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
    Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
    Saralamba S; Simpson JA; Choosri N; White L; Pan-Ngum W; Dondorp AM; White NJ
    J Antimicrob Chemother; 2023 Sep; 78(9):2192-2202. PubMed ID: 37473441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.